Research Topics
| Mitja LainscakSummaryAffiliation: University Medical Centre Country: Slovenia Publications
| Collaborators
|
Detail Information
Publications
Self-rated health predicts adverse events during beta-blocker treatment: The CIBIS-ELD randomised trial analysisMitja Lainscak
Division of Cardiology, University Clinic Golnik, Golnik, Slovenia Applied Cachexia Research, Division of Cardiology, Charite Campus Virchow Klinikum, Berlin, Germany Electronic address
Int J Cardiol 163:87-92. 2013..We aimed to evaluate the relation between SRH and adverse events during titration of beta-blockers in elderly patients with heart failure...
Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trialMitja Lainscak
Division of Cardiology, University Clinic or Respiratory and Allergic Diseases Colnik, Colnik, Slovenia
Respir Med 105:S44-9. 2011..This study compared effects of bisoprolol and carvedilol in patients with both conditions...
Biomarkers for chronic heart failureMitja Lainscak
Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany
Heart Fail Monit 5:77-82. 2007..Lastly, we anticipate the potential of biomarkers in a variety of chronic diseases with similar pathophysiology...
Treatment of chronic heart failure with carvedilol in daily practice: the SATELLITE survey experienceMitja Lainscak
Department of Internal Medicine, General Hospital Murska Sobota, Murska Sobota, Slovenia
Int J Cardiol 122:149-55. 2007..Beta-blockers are well established for treatment of chronic heart failure (CHF). However, the extent of implementation of trial results and guidelines in daily practice remains limited, and information regarding how patients feel is scarce...
Recall of lifestyle advice in patients recently hospitalised with heart failure: a EuroHeart Failure Survey analysisMitja Lainscak
Department of Internal Medicine, General Hospital Murska Sobota, Murska Sobota, Slovenia
Eur J Heart Fail 9:1095-103. 2007..There are limited data on recall and implementation of lifestyle advice in patients with heart failure (HF)...
Atrial fibrillation in chronic non-cardiac disease: where do we stand?Mitja Lainscak
Division of Cardiology, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
Int J Cardiol 128:311-5. 2008..In this paper, we review data on incidence, prognostic importance and treatment modalities of atrial fibrillation in patients with cancer, chronic obstructive pulmonary disease, and chronic kidney disease...
Cachexia: common, deadly, with an urgent need for precise definition and new therapiesMitja Lainscak
Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany
Am J Cardiol 101:8E-10E. 2008..Among the recognized approaches, exogenous oral amino acid supplementation appears very promising. Further research efforts are needed and they are ongoing...
How does cachexia influence survival in cancer, heart failure and other chronic diseases?Mitja Lainscak
Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany
Curr Opin Support Palliat Care 1:299-305. 2007..Ultimately, cachexia may develop in 10-15% of patients, who usually perish soon after. We currently have neither a globally accepted definition of cachexia nor any treatment to prevent or treat cachexia...
Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markersMitja Lainscak
Department of Cardiology, Division of Applied Cachexia Research, Campus Virchow Clinic, Charite Universitatsmedizin Berlin, Germany
Int J Cardiol 132:303-11. 2009..Finally, we speculate about the potential of sharing the biomarkers over a variety of chronic diseases with similar pathophysiology...
Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systemsMitja Lainscak
Division of Cardiology, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
Herz 34:141-7. 2009..There is limited evidence that the use of prognostic markers to make treatment decisions improves the outcome in CHF. Many studies still need to be done to this end...
The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failureMitja Lainscak
University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
Wien Klin Wochenschr 121:309-13. 2009..Our aim was to determine the prevalence and clinical impact of COPD among patients hospitalized for heart failure in a community hospital serving a population of 125,000 people...
Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challengesMitja Lainscak
Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow Clinic, Charite Universitatsmedizin, Berlin, Germany
Herz 34:589-93. 2009..The authors review some of those biomarkers and speculate on the possible roles of combining two or more of them...
Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1Mitja Lainscak
Division of Cardiology, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik 36, SI 4204 Golnik, Slovenia
Eur J Heart Fail 12:193-6. 2010..The MARVEL-1 trial raises further concerns about the safety of myoblast transplantation in ischaemic HF...
Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure SurveyMitja Lainscak
Department of Internal Medicine, General Hospital Murska Sobota, Murska Sobota, Slovenia
Am J Cardiol 99:31D-37D. 2007..In addition, a substantial proportion of those who recall the advice follow it incompletely. Younger age and prescription of appropriate pharmacologic treatment are associated with higher rates of recall and implementation...
Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot studyMitja Lainscak
General Hospital Murska Sobota, Internal Medicine Department, Dr Vrbnjaka 6 SI 9000, Murska Sobota, Slovenia
Int J Cardiol 106:319-22. 2006..Cachexia is an independent risk factor for mortality in chronic heart failure (CHF). Beta blockers can reduce body energy expenditure and improve efficiency of substrate utilization...
Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patientMitja Lainscak
Department of Internal Medicine, General Hospital Murska Sobota, 9000, Murska Sobota, Slovenia
Clin Rheumatol 26:1023-4. 2007..boydii infection in a patient with microscopic polyangiitis. Favorable outcome related to the treatment with voriconazole adds to the growing body of evidence supporting the use of this particular agent in P. boydii infections...
Heart failure clinic in a community hospital improves outcome in heart failure patientsMitja Lainscak
General Hospital Murska Sobota, Department of Internal Medcine, Slovenia
Swiss Med Wkly 136:274-80. 2006..We aimed to compare the outcome, pharmacological therapy, and quality of life in unselected heart failure patients from a community hospital area who were managed either in the heart failure clinic or who received the usual care...
Patient's view of heart failure: from the understanding to the quality of lifeMitja Lainscak
Internal Medicine Department, General Hospital Murska Sobota, Dr Vrbnjaka 6, SI 9000, Murska Sobota, Slovenia
Eur J Cardiovasc Nurs 2:275-81. 2003..Hospitalizations and symptoms of heart failure negatively influence patients' quality of life. In Slovenia there is a scarcity of non-pharmacological management and quality of life data in heart failure patients...
Validation of self assessment patient knowledge questionnaire for heart failure patientsMitja Lainscak
General Hospital Murska Sobota, Internal Medicine Department, Dr Vrbnjaka 6, SI 9000 Murska Sobota, Slovenia
Eur J Cardiovasc Nurs 4:269-72. 2005..Only a limited number of validated tools are available to assess their knowledge. The aim of the study was to test our 10-item Patient knowledge questionnaire...
Patients' knowledge and beta blocker treatment improve prognosis of patients from a heart failure clinicMitja Lainscak
General Hospital Murska Sobota, Internal Medicine Department, Dr Vrbnjaka 6, SI 9000 Murska Sobota, Slovenia
Eur J Heart Fail 8:187-90. 2006..Several studies have shown improvement of prognosis in patients managed in heart failure (HF) clinics. However, the value of the individual management components is not well established...
The management of patients with heart failure in a Slovenian community hospital: what has changed between 1997 and 2000?Mitja Lainscak
Internal Medicine Department, General Hospital, Murska Sobota, Slovenia
Wien Klin Wochenschr 115:334-9. 2003..There is a scarcity of data on changes in the management of patients hospitalized with heart failure...
International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure SurveyMitja Lainscak
Department of Internal Medicine, General Hospital Murska Sobota, Murska Sobota, Slovenia
Eur J Heart Fail 9:292-9. 2007..This may reflect a lack of adequate organisation of care or co-morbidity contra-indicating therapy...
Infective endocarditis due to Abiotrophia defectiva: a report of two casesMitja Lainscak
General Hospital Murska Sobota, Murska Sobota, Slovenia
J Heart Valve Dis 14:33-6. 2005..Endocarditis due to Abiotrophia sp. is rare and often associated with negative blood cultures. The rates of treatment failure, infection relapse and mortality are higher than in endocarditis caused by other viridans streptococci...
Anaemia is an independent predictor of death in patients hospitalized for acute heart failureStephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
Clin Res Cardiol 99:107-13. 2010..Acute heart failure is associated with a poor prognosis. It is important to identify patients at increased risk of adverse events. The presence of anaemia could help in this regard...
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trialHans Dirk Düngen
Department of Internal Medicine Cardiology, Charite Universitatsmedizin, Competence Network Heart Failure, Campus Virchow Klinkum, Berlin, Germany
Eur J Heart Fail 13:670-80. 2011..The aim of this study was therefore to compare the tolerability and clinical effects of two proven beta-blockers in elderly patients with heart failure...
Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trialHans Dirk Düngen
Department of Cardiology, Competence Network Heart Failure, Campus Virchow Klinkum, Charite Universitatsmedizin, Berlin, Germany
Clin Res Cardiol 97:578-86. 2008..Beta-blockers have further not been adequately tested in patients with diastolic CHF, which is particularly common in elderly patients. Finally, comparative data on the use of different beta-blockers in patients with CHF is scarce...
Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic reviewWolfram Doehner
Center for Stroke Research Berlin, Charite, Berlin, Germany
Wien Klin Wochenschr 121:293-6. 2009..Retrospective and epidemiological data for their beneficial effect in chronic obstructive pulmonary disease begin to accumulate and new fields (e.g. cancer and stroke) could be pending in the future...
Cardiac cachexia: a systematic overviewStephan von Haehling
Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
Pharmacol Ther 121:227-52. 2009..Other drug classes of interest comprise angiotensin-converting enzyme inhibitors, beta-blockers, anabolic steroids, beta-adrenergic agonists, anti-inflammatory substances, statins, thalidomide, proteasome inhibitors, and pentoxifylline...
Feasibility of transcutaneous electrical muscle stimulation in acute exacerbation of COPDUros Meglic
The University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik, Slovenia
Wien Klin Wochenschr 123:384-7. 2011..Our results set the stage for future research to determine specific benefit of transcutaneous electrical muscle stimulation, either alone or in combination with nutritional support and pharmacological therapy...
Mini nutritional assessment, body composition, and hospitalisations in patients with chronic obstructive pulmonary diseaseBarbara Benedik
University Clinic or Respiratory and Allergic Diseases Colnik, Colnik, Slovenia
Respir Med 105:S38-43. 2011..We have conceived this analysis to study the associations between MNA questionnaire, body composition, and rehospitalisations in patients with COPD...
Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failureTibor Szabo
Applied Cachexia Research, Department of Cardiology, Campus Virchow Klinikum, Charite University Medical School, Berlin, Germany
Int J Cardiol 147:47-51. 2011..Their value and discriminatory power in comparison to dynamic range assessment of Si by minimal modelling are not well established...
Overview of emerging pharmacotherapy in chronic heart failureTibor Szabo
Charite Medical School, Campus Virchow Klinikum, Applied Cachexia Research, Department of Cardiology, Augustenburger Platz 1, 13353 Berlin, Germany
Expert Opin Pharmacother 10:2055-74. 2009..This review will focus on recent developments and potential future candidates of pharmacological CHF therapy...
Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: A randomized double-blinded placebo-controlled studyWolfram Doehner
Center for Stroke Research Berlin, Charite Universitatsmedizin Berlin, Germany Electronic address
Int J Cardiol 161:137-42. 2012..We aimed to test the ancillary metabolic effect of irbesartan on insulin sensitivity in patients with CHF...
Atrial natriuretic peptide and related peptidesYoshihiro J Akashi
Division of Applied Cachexia Research, Center for Cardiovascular Research, Charite Campus Mitte, Berlin, Germany
Clin Chem Lab Med 45:1259-67. 2007..This article summarizes existing data on ANP and related peptides in cardiovascular and other disorders, and outlines the potential clinical usefulness of these markers...
Inflammatory biomarkers in heart failure revisited: much more than innocent bystandersStephan von Haehling
Department of Cardiology, Applied Cachexia Research, Charite Medical School, Berlin, Germany
Heart Fail Clin 5:549-60. 2009..In addition to these acute phase reactants, several adhesion molecules, and lipopolysaccharide-signaling pathways are discussed...
Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary diseaseIrena Sarc
University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik, Slovenia
J Eval Clin Pract 17:737-43. 2011..This retrospective study aimed to assess the implementation of COPD guidelines and potential association with long-term mortality in patients with COPD...
Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary diseaseRobert Marcun
Department of Pneumology, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
Int J Cardiol 161:156-9. 2012..We aimed to investigate associations between N-terminal pro B-type natriuretic peptide (NT-proBNP) and troponin T during hospitalisation with 6-month outcome...
Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary diseaseWolfram Doehner
Center for Stroke Research Berlin, Charite Medical School, Berlin, Germany
Respir Med 105:S12-9. 2011..Impaired glucose metabolism ranges from insulin resistance to overt diabetes mellitus, which is a frequent finding and is associated with worse outcome...
Treatment of pulmonary hypertension: bench to bedsideJochen Springer
Applied Cachexia Research, Charite Universitaetsmedizin Berlin, Berlin, Germany
Respir Med 105:S7-11. 2011..On the other hand, there have been failures such as vasoactive intestinal peptide, statins, and escitalopram. Several new drugs and gene therapy are under investigation, thus significant advances are anticipated...
Venous thromboembolism prophylaxis in hospitalized patients with pneumonia: a prospective surveyPetra Jancar
University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
Wien Klin Wochenschr 121:318-23. 2009..There is little information on the preventive use of low-molecular-weight heparin (LMWH) in hospitalized patients with pneumonia...
Implementation of guidelines for management of heart failure in heart failure clinic: effects beyond pharmacological treatmentMitja Lainscak
Internal Medicine Department, General Hospital Murska Sobota, Dr Vrbnjaka 6, SI 9000 Murska Sobota, Slovenia
Int J Cardiol 97:411-6. 2004..Intensive multidisciplinary approach can improve management of the patients with heart failure...
Estimation of renal function in lung cancer patientsKatja Trobec
Pharmacy Department, University Clinic Golnik, Golnik 36, 4204 Golnik, Slovenia
Lung Cancer 76:397-402. 2012....
Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two?Stanislav Suskovic
Stanislav Suskovic, Department for Clinical Audit, University Clinic for Respiratory and Allergic Diseases Golnik, SI 4204 Golnik, Slovenia
World J Cardiol 2:305-7. 2010..Routine spirometry and echocardiography in HF and COPD patients, respectively, is therefore warranted to improve current clinical practice...
Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of CardiologyMitja Lainscak
Division of Cardiology, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik 36 SI 4204 Golnik, Slovenia
Eur J Heart Fail 13:115-26. 2011..It also defines avenues of research to optimize self-care strategies in a number of key areas to derive further benefits...
Challenges of beta blocker therapy in chronic heart failure: the story continuesMitja Lainscak
Eur J Cardiovasc Nurs 7:159-60. 2008..Nurse specialist has a decisive role in implementation of evidence based management which can have effects beyond patient care...
Assessment of physical fitness in adults by field testing supported by the specific software for personal computer based useZlatko Fras
University Medical Centre, Department of Vascular Medicine, Ljubljana, Slovenia CINDI Slovenia, Ljubljana, Slovenia
Comput Biol Med 37:1377-83. 2007..The test was integrated to exercise related health promotion programme, and widely available information technologies will be used for data management...
Metabolic disturbances in chronic heart failure: a case for the "macho" approach with testosterone?!Mitja Lainscak
Eur J Heart Fail 9:2-3. 2007..We discuss this study in detail. Further studies are needed to substantiate this link and to generally explore the value of testosterone therapy in CHF patients...
Recommendations on sub-speciality accreditation in cardiology: The Coordination Task Force on Sub-speciality Accreditation of the European Board for the Speciality of CardiologyJose Lopez-Sendon
Cardiology Department, Planta 1, Hospital Universitario La Paz, Paseo de la Castellana 261, Madrid, Spain
Eur Heart J 28:2163-71. 2007
Survival and body fat in hemodialysis patients: true association or effects of concomitant therapy?Anja Sandek
Am J Clin Nutr 84:663-4; author reply 634. 2006
Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary diseaseMitja Lainscak
Intern Med 45:837. 2006
The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance doseDarja Herman
Institute of Biochemistry, Faculty of Medicine, Ljubljana, Slovenia
Eur J Clin Pharmacol 62:291-6. 2006..As, in many patients, drug co-treatment cannot be avoided, we investigated the effect of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose...
Prognostic role of body mass index after acute myocardial infarctionMitja Lainscak
Am J Cardiol 98:1556-7. 2006
